R&D Centre will be housed in Baddi and will cater to all business divisions in addition to expansion plans for all its verticals including APls, Formulations and Medical Devices
Gujarat Themis Biosyn has reported total income of Rs.93.82 crores for FY 2020-21
The jump in profit is due to the better performance of the API business.
The company has reported total income of Rs.25699.68 crores during the 9 months period ended December 31, 2020.
The figures highlight double-digit revenue growth, margin expansion, and continued momentum in complex generics and peptides CDMO platform
Rs. 40 cr buyback, 200% dividend announced
Net sales reached CHF 1,327.8 million, up 2.6% year-on-year in Swiss francs, or 4.3% at constant exchange rates
U.S. market achieved record quarterly sales of Rs. 3,113.2 crore ($350 million), a 54% YoY increase, accounting for 44% of global sales
Subscribe To Our Newsletter & Stay Updated
